ENVUE MEDICAL INC (FEED)
NASDAQHealth CareMedical - SpecialtiesSnapshot 2026-09-04
$4.03+5.22%
Close 2026-09-04 · 1-day change
NASDAQHealth CareMedical - SpecialtiesSnapshot 2026-09-04
QuarterlyIQ Insights · FEED
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance sits below its industry cohort — worth keeping an eye on, though it has not freshly broken.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | 184.1% |
| Our one-year growth estimate | diamond |
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
No outside relationship met the current evidence threshold.
Based on historical daily prices through 2026-09-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| -70.7% |
Growth built into the price is above our model estimate.
The price assumes 254.8 percentage points more one-year growth.
The one-year revenue growth assumption on Valuation.
Worth watching into the next print: this name is a smaller-cap name (higher miss base rate) and has erratic recent earnings surprises. A fundamental tilt, not a price call.
Model as of 2026-09-04 · Compared with 9 industry peers · Company calendar date is not available
FEED — legal / regulatory event — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standar…
Dated 2026-07-10
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On July 10, 2026, ENvue Medical, Inc. (the “Company”) received a letter (the “Staff Determination Letter”) from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that the Staff has determined that the closing bid price of the Company’s common stock, par value $0.001 per share (the “Common Stock”), has been below $1.00 per share…
Why it matters: Revenue growth is key for the company. A strong Q2 would show progress in sales.
Supportive ifQ2 revenue reported above $653K, showing continued growth.
Worry ifQ2 revenue was below $653K. This shows no growth.
Why it matters: A drop in revenue affects the company's finances. It is important to stabilize or grow revenue.
Supportive ifRevenue increases quarter over quarter, reaching at least $0.50M in Q3.
Worry ifRevenue continues to decline, falling below $0.20M in Q3.
Why it matters: The company risks delisting if its stock price stays below $1.00. This affects investor confidence.
Worry ifThe closing bid price stays above $1.00 per share for two consecutive weeks.
Less concerning ifThe closing bid price remains below $1.00 per share for two consecutive weeks.
Why it matters: The company is reducing its net losses. This improvement is important for investor trust.
Supportive ifNet income losses decrease further from negative $3.8M in Q1.
Worry ifNet income losses increase or remain stagnant at negative $3.8M.
We watch for confirming and disproving signals on each item. Resolutions are found automatically where possible and checked by hand for unclear cases. Last 90 days shown.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$429 on $10,000 · ±4.3% | How much price usually moves either way. |
| Bad day | $1,090 loss on $10,000 · 10.9% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $9,366 loss on $10,000 · 93.7% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.
Why it matters: If sector revenue growth slows, it may impact Envue Medical's performance. This could signal broader challenges.
Worry ifSector revenue growth has been below average for two months in a row.
Less concerning ifSector revenue growth is steady or better than average.
Why it matters: The company received a notice about its stock price being below $1.00. This affects its listing status.
Worry ifThe company made a public announcement. It shows they follow Nasdaq listing rules.
Less concerning ifMore notices or actions show that the company still does not follow Nasdaq rules.
Why it matters: A return to higher revenue growth in healthcare could benefit Envue.
Supportive ifHealthcare sector revenue growth is speeding up to 9% or more.
Worry ifHealthcare sector revenue growth is slowing down.
Why it matters: This report will show if the company can improve its financial performance. Investors will focus on revenue and loss trends.
Watch forEarnings report shows revenue growth above 5% compared to the previous quarter.
Also watch forEarnings report shows revenue decline or losses greater than 10%.
Why it matters: The company faces a risk of delisting due to its stock price. Updates will show if it can stay listed.
Worry ifA statement confirming that the stock price is above $1.00 after the earnings report.
Less concerning ifA further notice of delisting or continued low stock price below $1.00.
Why it matters: The reverse stock split aims to boost the stock price above $1. This is crucial for Nasdaq compliance.
Supportive ifThe stock price remains above $1.00 for at least 10 consecutive trading days after September 1, 2026.
Worry ifThe stock price falls back below $1.00 within 30 days after the split.
Why it matters: Following Nasdaq rules is important to avoid being removed from the exchange. This impacts how investors feel.
Worry ifNasdaq confirms that ENvue Medical is in compliance with listing rules after the reverse split.
Less concerning ifNasdaq sends another notice about delisting due to price or rule problems.
Why it matters: Getting this facility is key for cash flow. It helps keep operations running and supports growth.
Supportive ifThe company will use the equity fund in the next quarter.
Worry ifThe company does not use the equity facility or has delays.
Why it matters: Revenue growth is crucial for the company's stability. A decline signals deeper issues.
Worry ifRevenue shows a quarter-over-quarter increase from the current low of $239,000.
Less concerning ifRevenue continues to decline or stays flat in the next two quarters.